
Zantac Heartburn Medication
In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication Zantac exposes users to unsafe levels of the carcinogen N-Nitrosodimethylamine (NDMA). (Dimesky et al v. Sanofi-Aventis U.S., LLC, Sanofi US Services Inc., Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-1517, D. CT.)
Class-Action Tracker

The Latest

Renewal by Andersen’s ‘Made in USA’ Window Dressing
TINA.org files FTC complaint against company.

Ariat’s WorkHog Patriot Boots
Don’t let the American flags fool you.

NuBest Height Growth Supplements for Kids and Teens
Can supplements really help your child reach new heights?

Monetizing Minors
How brands exploit kid influencers and their followers.

Keppal’s Made in USA Claims
TINA.org digs into online retailer’s U.S.-origin claims following consumer tip.